Submit
logo

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 09-07-2018
AUM:

₹ 6,668.95 Cr

Expense Ratio

1.87%

Benchmark

BSE Healthcare TRI

ISIN

INF109KC1GG4

Minimum Investment

5000.0

Minimum Topup

1000.0

Minimum SIP Amount

100

Fund Manager

Dharmesh Kakkad

Fund Performance 1Y (%) 3Y (%) 5Y (%)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option 4.84 25.44 14.41
Benchmark - - -
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
23.9
Last change
0.03 (0.1255%)
Fund Size (AUM)
₹ 6,668.95 Cr
Performance
19.04% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Manager
Dharmesh Kakkad
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 11.76
CIPLA LIMITED EQ NEW FV RS.2/- 8.15
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- 7.58
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- 6.06
Dr. Reddys Laboratories Ltd 5.94
BIOCON LIMITED EQ 5.81
SUVEN PHARMACEUTICALS LIMITED EQ 4.44
LUPIN LIMITED EQ NEW F.V. RS.2/- 3.8
MEDPLUS HEALTH SERVICES LIMITED EQ NEW FV RS.2/- 3.37
ALKEM LABORATORIES LIMITED EQ 3.24

Sector Allocation

Sector Holdings (%)
Healthcare 89.26
Consumer Services 5.09
Financial Services 1.25
Chemicals 1.15

Peer Comparison

Scheme Name 5Y (%)
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund IDCW 14.41